Skip to content

MAIA Biotechnology, Inc.: 10-Q filed 2024-08-09

What MAIA Biotechnology, Inc. reported in its quarterly report filed 2024-08-09 (fiscal Q2 2024): 32 published measures, 94 facts as tagged in accession 0000950170-24-094747.

This filing

Form
10-Q (quarterly report)
Filed
2024-08-09
Fiscal period
fiscal Q2 2024
Accession
0000950170-24-094747 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MAIA Biotechnology, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3012,019,608USD
At 2023-12-317,566,852USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-308,857,713USD
At 2023-12-317,089,341USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-300USD
At 2023-12-310USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-8,271,571USD182
2023-01-01 to 2023-06-30-5,921,281USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-3012,704,327USD182
2023-01-01 to 2023-06-304,119,522USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-80,926,908USD
At 2023-12-31-63,980,177USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3022,203,174shares91
2024-01-01 to 2024-06-3019,906,043shares182
2023-04-01 to 2023-06-3012,885,134shares91
2023-01-01 to 2023-06-3011,931,319shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3022,203,174shares91
2024-01-01 to 2024-06-3019,906,043shares182
2023-04-01 to 2023-06-3012,885,134shares91
2023-01-01 to 2023-06-3011,931,319shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.4USD/shares91
2024-01-01 to 2024-06-30-0.85USD/shares182
2023-04-01 to 2023-06-30-0.35USD/shares91
2023-01-01 to 2023-06-30-0.72USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.4USD/shares91
2024-01-01 to 2024-06-30-0.85USD/shares182
2023-04-01 to 2023-06-30-0.35USD/shares91
2023-01-01 to 2023-06-30-0.72USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-01-01 to 2024-06-300USD182
2023-01-01 to 2023-06-300USD181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-06-30763,913USD182
2023-01-01 to 2023-06-301,156,453USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,815,262USD91
2024-01-01 to 2024-06-30-7,764,138USD182
2023-04-01 to 2023-06-30-4,664,646USD91
2023-01-01 to 2023-06-30-8,848,896USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-3012,016,808USD
At 2023-12-317,564,052USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,715USD91
2023-01-01 to 2023-06-306,862USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-303,511,075USD
At 2023-12-314,937,153USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-06-301,263,788USD
At 2023-12-311,638,546USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-303,815,262USD91
2024-01-01 to 2024-06-307,764,138USD182
2023-04-01 to 2023-06-304,664,646USD91
2023-01-01 to 2023-06-308,848,896USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-302,052,233USD91
2024-01-01 to 2024-06-304,372,975USD182
2023-04-01 to 2023-06-302,599,315USD91
2023-01-01 to 2023-06-304,795,306USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3023,737,833shares
At 2023-12-3116,986,254shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-06-3011,579,391USD
At 2023-12-317,150,695USD
At 2023-06-309,146,156USD
At 2022-12-3110,950,927USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-3084,108,607USD
At 2023-12-3164,472,249USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-06-30-22,178USD
At 2023-12-31-16,260USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-06-303,161,895USD
At 2024-03-31-5,764,928USD
At 2023-12-31477,511USD
At 2023-06-306,874,334USD
At 2023-03-315,083,208USD
At 2022-12-318,507,793USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-06-302,800USD
At 2023-12-312,800USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-06-302,247,287USD
At 2023-12-313,298,607USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-06-30259,730USD
At 2023-12-31268,677USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-8,879,276USD91
2024-01-01 to 2024-06-30-16,946,731USD182
2024-01-01 to 2024-03-31-8,067,455USD91
2023-04-01 to 2023-06-30-4,523,624USD91
2023-01-01 to 2023-06-30-8,640,500USD181
2023-01-01 to 2023-03-31-4,116,876USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-8,871,408USD91
2024-01-01 to 2024-06-30-16,952,649USD182
2023-04-01 to 2023-06-30-4,524,258USD91
2023-01-01 to 2023-06-30-8,650,435USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-8,879,276USD91
2024-01-01 to 2024-06-30-16,946,731USD182
2023-04-01 to 2023-06-30-4,523,624USD91
2023-01-01 to 2023-06-30-8,640,500USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,763,029USD91
2024-01-01 to 2024-06-303,391,163USD182
2023-04-01 to 2023-06-302,065,331USD91
2023-01-01 to 2023-06-304,053,590USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-372,786USD182
2023-01-01 to 2023-06-30384,667USD181

Inspect the source

Entity
MAIA Biotechnology, Inc. / CIK 0001878313
Captured
2026-09-21T17:32:44.689Z
SEC response SHA-256
5b0d21820d4dfe5511136b7d6b5b836f6005971af7e031dc33e7f5755064abc0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001878313.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))